U.S. FDA clears exoskeleton for stroke rehab
Reuters
The U.S. Food and Drug Administration has cleared Wandercraft's self-balancing exoskeleton for use in stroke rehabilitation. In July 2021, Reuters was given a first-hand demonstration of the possibilities wearable exoskeletons can have for people with disabilities.
Reuters
Most Popular
0 of 9 videos
Latest
0 of 10 videos
Canada
0 of 10 videos
World
0 of 10 videos
Life & Arts
0 of 10 videos
Drive
0 of 10 videos
Business & Investing
0 of 10 videos